Parenterals and Injectables

Symbiosis Announces Plans to Open US Office

February 16, 2017

The new commercial site, set to be located in Cambridge, Boston, MA, will serve clients on both the East and West Coast. It will also be the base for reaching new customers in the area.

Ensuring Sterility in Small-Scale Production

February 02, 2017

Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses how to ensure sterility when manufacturing small-scale parenteral batches.

SGS Expands Extractables and Leachables Testing

January 25, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

SGS invested in test equipment for analyzing extractables and leachables at its New Jersey laboratory.

Vetter Starts Operations in Its Center for Visual Inspection and Logistics

January 25, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Vetter expanded visual inspection facilities and controlled-temperature storage at its Ravensburg Vetter West facility in Germany.

Advances in Delivering Protein and Peptide Therapeutics

November 02, 2016

A variety of strategies have been employed to deliver proteins and peptides in improved parenteral formulations and/or via noninvasive routes.

PTSM: Pharmaceutical Technology Sourcing and Management

Looking for a Root Cause of Parenteral Contaminants

October 05, 2016

Multiple inspection techniques facilitate the identification of particulate matter in vials as part of root-cause investigations and safety evaluations.

Protecting Parenterals in Primary Packaging

October 02, 2016

Primary packaging and manufacturing technologies minimize product/package interaction, protect quality, support safe travel through the supply chain, and enhance performance at point of use.

Aptar Stelmi Presents Alternative Coated Stopper for Sensitive Drugs

September 22, 2016

Aptar Stelmi will present PremiumCoat, an alternative coated stopper for sensitive drugs, at CPhI 2016.

Taking a Closer Look at Parenteral Contaminants

September 02, 2016

Visual inspection of parenteral vials is the first step in a root cause investigation.

Parenteral Advisory: Outmoded Fill/Finish Technology

September 01, 2016

Improvements to aseptic manufacturing procedures are long overdue. But how feasible is it for manufacturers to modernize fill lines of legacy products?